Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement The collaboration and license agreement with Schrödinger aims to advance “multiple” small molecule candidates into Novartis’ portfolio for further development.
Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement The collaboration and license agreement with Schrödinger aims to advance “multiple” small molecule candidates into Novartis’ portfolio for further development.
